Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.

Carvajal R, Marcialis C, Tur C, Otero-Romero S, Roos I, Pappolla A, Novak F, Cobo-Calvo A, Ariño H, Arrambide G, Bollo L, Casallas-Vanegas A, Castilló J, Comabella M, Driemeyer C, Elosua I, Fadrique C, Galán I, Grávalos M, La Puma D, Masot A, Midaglia L, Molina-Goicoechea M, Mongay-Ochoa N, Rodríguez-Acevedo B, Río J, Tagliani P, Vidal-Jordana A, Vilaseca-Jolonch A, Zabalza A, Pugliatti M, Sastre-Garriga J, Kalincik T, Montalban X, Tintore M

Open source

DOI
10.1136/jnnp-2026-338694
Published
2026 Sep 14
Container
Journal of neurology, neurosurgery, and psychiatry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jnnp-2026-338694,
  title = {Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.},
  author = {Carvajal R and Marcialis C and Tur C and Otero-Romero S and Roos I and Pappolla A and Novak F and Cobo-Calvo A and Ariño H and Arrambide G and Bollo L and Casallas-Vanegas A and Castilló J and Comabella M and Driemeyer C and Elosua I and Fadrique C and Galán I and Grávalos M and La Puma D and Masot A and Midaglia L and Molina-Goicoechea M and Mongay-Ochoa N and Rodríguez-Acevedo B and Río J and Tagliani P and Vidal-Jordana A and Vilaseca-Jolonch A and Zabalza A and Pugliatti M and Sastre-Garriga J and Kalincik T and Montalban X and Tintore M},
  year = {2026},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  doi = {10.1136/jnnp-2026-338694},
  url = {https://doi.org/10.1136/jnnp-2026-338694}
}

RIS

TY  - JOUR
TI  - Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.
AU  - Carvajal R
AU  - Marcialis C
AU  - Tur C
AU  - Otero-Romero S
AU  - Roos I
AU  - Pappolla A
AU  - Novak F
AU  - Cobo-Calvo A
AU  - Ariño H
AU  - Arrambide G
AU  - Bollo L
AU  - Casallas-Vanegas A
AU  - Castilló J
AU  - Comabella M
AU  - Driemeyer C
AU  - Elosua I
AU  - Fadrique C
AU  - Galán I
AU  - Grávalos M
AU  - La Puma D
AU  - Masot A
AU  - Midaglia L
AU  - Molina-Goicoechea M
AU  - Mongay-Ochoa N
AU  - Rodríguez-Acevedo B
AU  - Río J
AU  - Tagliani P
AU  - Vidal-Jordana A
AU  - Vilaseca-Jolonch A
AU  - Zabalza A
AU  - Pugliatti M
AU  - Sastre-Garriga J
AU  - Kalincik T
AU  - Montalban X
AU  - Tintore M
PY  - 2026
JO  - Journal of neurology, neurosurgery, and psychiatry
DO  - 10.1136/jnnp-2026-338694
UR  - https://doi.org/10.1136/jnnp-2026-338694
ER  - 

APA

R, C., C, M., C, T., S, O., I, R., A, P., F, N., A, C., H, A., G, A., L, B., A, C., J, C., M, C., C, D., I, E., C, F., I, G., M, G., D, L. P., A, M., L, M., M, M., N, M., B, R., J, R., P, T., A, V., A, V., A, Z., M, P., J, S., T, K., X, M., & M, T. (2026). Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.. Journal of neurology, neurosurgery, and psychiatry. https://doi.org/10.1136/jnnp-2026-338694

Source records